Final Program

Welcome and Introduction
Dr. Shelley Deeks, Public Health Agency of Canada

Dr. Joanne Embree, Canadian Paediatric Society

Mr. Steven Fletcher, Parliamentary Secretary to the Minister of Health and Minister for the Federal Economic Development Initiative for Northern Ontario

*Dr. David Butler-Jones, Chief Public Health
Officer, Public Health Agency of Canada

Ms. Kerri Irvin-Ross, Minister of Healthy Living (Manitoba)

Grade 6 Student Poster Competition - Announcement of Winner and Ceremony
Hall B, 3rd Floor

*Dr. David Butler-Jones, Public Health Agency
of Canada
Dr. Ian Gemmill, Canadian Coalition for
Immunization Awareness and Promotion
Dr. David Allison, Canadian Coalition for
Immunization Awareness and Promotion

Viral Diseases and Vaccines
Hall B, 3rd Floor
Chair: Dr. Bhagirath Singh, Canadian Institutes of Health Research

Potential Cost-Effectiveness
of Vaccination Against Herpes
Zoster and Post-Herpetic
Neuralgia in Canada
Dr. Marc Brisson, Laval University

Impact of a One Day Workshop
on Public Health Professionals’
Knowledge, Attitudes and
Beliefs on HPV Infection,
Screening and Vaccination
Dr. Vladimir Gilca, Laval University Hospital Centre

Epidemiology of Mumps
in Canada
Ms.Tammy Lipskie, Public Health Agency
of Canada

Parental Knowledge and
Beliefs Surroundings Varicella
and the Varicella Vaccine
Dr. Marian MacLellan, St. Francis Xavier
University

Update on Molecular
Epidemiology of Measles,
Mumps, Rubella and
Varicella-Zoster in Canada
Dr. Graham Tipples, National Microbiology
Laboratory

Detection of Human Influenza
Virus in the Stool of Children
Dr. Susan Wootton, Vaccine Evaluation Centre

The Health and Economic
Burden of HPV Infection, Genital
Warts, Cervical Dysplasia and
Cervical Cancer in Canada
Dr. Marc Brisson, Laval University

Public Health Research
Room 2E, 2nd Floor
Chair: Dr. Jim Dickinson, University of Calgary

Reported Cases of Facial
Paralysis Following
Immunization in Canada
Ms. Helen Anyoti, Public Health Agency
of Canada

Influenza and the Health Care
Workforce: Identifying Barriers
and Facilitators to Vaccine
Uptake in British Columbia
Dr. Jane Buxton, BC Centre for Disease Control

Cost-Effectiveness of Universal
Hepatitis A Vaccination
in Canada
Dr. Bernard Duval, Centre hospitalier
universitaire de Québec

Versatility of Electronic
Immunization Database for
Determining Coverage Rates
Ms. Jeanette Humphries, Public Health Services

The Effect of a Universal
Influenza Immunization Program
on Influenza-Related
Hospitalizations and Mortality
Dr. Jeff Kwong, Institute for Clinical
Evaluative Sciences

A Canadian Survey
of Immunization Practices
Following Hematopoietic Stem
Cell Transplantation in Adults
Ms. Monique McFarlane, Canadian Centre
for Vaccinology

Health Professionals Survey:
Knowledge, Attitudes and
Practices About HPV Vaccines
Use and Their Potential Impact
on Cervical Cancer Screening
Dr. Bernard Duval, Centre hospitalier universitaire de Québec

Issues in Under-Immunized
Populations: The Tale of Three
Outbreaks
Dr. Bryna Warshawsky, Middlesex-London
Health Unit

Bacterial Diseases
and Vaccines
Room 2F, 2nd Floor
Chair: Dr. David Scheifele, British Columbia Children’s Hospital

Impact of Infant Vaccination
Against Invasive Pneumococcal
Disease in Vancouver-Coastal
and Fraser Health Authorities
Ms. Gordean Bjornson, Vaccine Evaluation Centre

The International Circumpolar
Surveillance System for
Population-Based Surveillance
of Invasive Pneumococcal
Disease 1999-2004
Dr. Michael Bruce, Centers for Disease Control and Prevention

Increase in Invasive
Pneumococcal Disease in
Alaska Native Children Due to
Serotypes Not in the Heptavalent
Pneumococal Conjugate Vaccine
2001-2005
Ms. Tammy Cottle, Arctic Investigations
Program, Centers for Disease Control
and Prevention

Kinetics of the Serum IGG and
IGA Antibody Response (ABR)
in Healthy Women of Child-
Bearing Age After Immunization
with TDAP
Ms. Beth Halperin, Dalhousie University

Attitudes, Beliefs and Knowledge
Associated With Increased
Uptake of Meningococcal C
(MENC) Vaccination Among
Toronto High School Students
Mr. Olayem Kadri, Toronto Public Health Canada

Vaccine-Preventable Empyema
Due to Community-Acquired
Pneumonia in Canadian Children:
A Pediatric Investigator’s
Collaborative Study on Infections
in Canada (PICNIC) Study
Dr. Joanne Langley, Dalhousie University

Long Term Efficacy of 23-Valent
Pneumococcal Polysaccharide
Vaccine (PPV) in Ontario
Dr. Zhong Liu, Mount Sinai University

Vaccinating Adolescents Against
Meningococcal Disease in
Canada: A Cost-Effective Analysis
Dr. Philippe De Wals, Laval University

The National Immunization Strategy: Direction of the Immunization Program
Hall B, 3rd Floor
Chair: Dr. Ian Gemmill, Canadian Public
Health Association/National Specialty Society for Community Medicine

The View From Here - Federal
Perspective
Dr. Theresa Tam, Public Health Agency
of Canada

The View From Here -
Provincial/Territorial Perspective
Dr. Greg Hammond, Manitoba Health

The View From Here - Local Perspective
Dr. David Roseman, Alberta Medical Association

Changes and Impact
of Immunization Programs
Hall B, 3rd Floor
Chair: Dr. Shelley Deeks,
Public Health Agency of Canada

Meningoccal Conjugate - U.K.
Experience
Dr. Elizabeth Miller, Health Protection Agency, United Kingdom

Pneumococcal Conjugate -
Alberta (Canadian) Experience
Dr. Jim Kellner, Alberta Children’s Hospital

Varicella - U.S. Experience
Dr. Jane Seward, Centers for Disease Control and Prevention, United States

Acellular Pertussis in Adolescents/Adults - Prince Edward Island (Canadian) Experience
Dr. Scott Halperin, Dalhousie University

Influencing Public Policy
Hall B, 3rd Floor

Chair: Dr. Elinor Wilson, Canadian Public Health Association

This session will focus on the many factors and sectors that influence decisions related to public funding for immunization programs: How do governments make decisions, and what do they need to know? Who do they listen to and why? What are the most compelling arguments? What about the public? Participants will hear from those who have been advocates and those who have had to manoeuvre policies through government bureaucracies.

How to Assist Government Decision Making
Dr. Ross Findlater, Saskatchewan Health

The Role of Economics in Building Healthy Public Policy
Dr. Alan Shiell, University of Calgary

How a Non-governmental Organization and Its Members Can Advocate for Immunization
Ms. Marie-Adèle Davis, Canadian Paediatric Society

Vaccine Safety Surveillance in Canada and Beyond - Who Does What and Why
Room 2E, 2nd Floor

Chair: Dr. Barbara Law, Public Health Agency of Canada

The roles, responsibilities and challenges of contributing to Canada's vaccine safety network at the vaccine provider, provincial/territorial and national levels will be discussed, using illustrative case scenarios.

Communicating About Vaccine Safety: The Vaccine Provider Perspective
Dr. Noni MacDonald, Dalhousie University

Responding to Vaccine Safety Issues at the Provincial Level: The Quebec ESPRI Approach
Dr. Michèle Tremblay, Direction de santé publique de Montréal (Presentation will be in French)

Assessing Causality When Adverse Events Follow Immunization: The ACCA Experience
Dr. Barbara Law, Public Health Agency of Canada

Practical Immunization
Room 2F, 2nd Floor

Chair: Ms. Karen Pielak, Canadian Nursing Coalition for Immunization

This session will provide information and the opportunity for discussion about very practical issues in immunization delivery. Safety is an important consideration during the immunization encounter - for both the client and the immunization provider. Presentations will cover such issues as child restraint, the monitoring of vaccine administration errors, needle stick injuries, the use of safety-engineered needles and immunization technique. Maintenance of the vaccine cold chain is also integral to a safe and effective immunization program. There will be a presentation on the recently revised National Guidelines for maintenance of the vaccine cold chain.

Client Safety During Immunization
Ms. Jean Pagnucco, Nurse Practice Consultant, Alberta

Vaccine Provider Safety During the Immunization Encounter
Ms. Felicity Hemming, Fraser Health Authority, British Columbia

Revised National Guidelines for Maintenance of the Vaccine Cold Chain
Ms. Suchita Jain, Public Health Agency of Canada

Immunization Debates
Room 2G, 2nd Floor

Chair: Dr. Monika Naus, British Columbia Centre for Disease Control

This session will be an opportunity to take part in debates on two topics. The first is the long-standing issue on whether seasonal vaccination against influenza should be “mandatory” for health care providers. On the one hand, there is the science to support this practice as a standard of care, especially for the protection of vulnerable elderly people; on the other hand, there are issues related to autonomy and other considerations. The second issue is increasingly important, as our vaccine programs become more costly; it is that of the need to consider economic factors in the formulation of recommendations on new immunization programs. Come prepared to share your views to add to this friendly exchange, as we strive to understand the myriad sides of the coin and pursue a meeting of the minds.

Mandatory Influenza Immunization of Health Care Workers
Pro: Dr. Allison McGeer, Mount Sinai Hospital/Toronto Medical Laboratories
Con: Dr. Ross Upshur, University of Toronto

Rational Rationing of Vaccines
Pro: Dr. Philippe De Wals, Laval University
Con: Dr. Richard Mathias, University of British Columbia

International Issues
Pan Am Room, 2nd Floor

Chair: Dr. Elwyn Griffiths, Health Canada

Mumps in the United Kingdom
Dr. Elizabeth Miller, Health Protection Agency, United Kingdom

Zoster Vaccine: A New Vaccine
for Prevention of Herpes
and Post-herpetic Neuralgia
Dr. Jane Seward, Centers for Disease Control and Prevention, United States

International Measles Initiative
Dr. Gaston De Serres, Institut national de santé publique du Québec (Presentation will be in French)

Rotavirus, Hall B, 3rd Floor

Chair: Dr. Elwyn Griffiths, Health Canada

A number of new rotavirus vaccines are now on the horizon. Immunization against rotavirus is aimed at inducing immunity against relevant serotypes, and this complicates vaccine development strategies. The development of any new rotavirus vaccine cannot ignore the events which led to the withdrawal of one vaccine from the market a few years ago, when an epidemiological relationship was established between vaccination and intersucception. Clinical evaluation of new vaccines will focus especially on both pre- and post-licensure studies to evaluate the incidence of intersucception in the recipient population.

Rotavirus Disease in Canada
Dr. Lisa Landry, Public Health Agency of Canada

Rotavirus Vaccines
Dr. Elizabeth Lee Ford-Jones, Hospital for Sick
Children and University of Toronto

Rotavirus in the United States
Dr. Umesh Parashar, Centers for Disease Control and Prevention

Human Papilloma Virus
Room 2E, 2nd Floor

Chair: Dr. Simon Dobson, British Columbia Children's Hospital

Human papilloma virus (HPV) vaccines will soon be available. Key to the decision by a parent or teenager to receive any vaccine is the recommendation by and endorsement of their health care provider. How much do you know about HPV, the diseases associated with HPV and the new vaccines?

HPV and Cervical Cancer… Cause for Both Concern and Opportunity
Dr. Wylam Faught, University of Alberta

HPV Vaccines… The Opportunity and What to Expect
Dr. Deborah Money, University of British Columbia

The Vaccine and Knowledge... Who is Concerned About What and Why?
Dr. Shelly McNeil, Nova Scotia Queen Elizabeth II
Health Sciences Centre

Special Indications for Vaccination
Room 2F, 2nd Floor

Chair: Dr. Carol Kurbis, Winnipeg Regional Health Authority

This session will provide an overview of immunization programs in an occupational health setting, current immunization hot topics in travel medicine and an overview of intradermal administration of rabies vaccine.

Employment Vaccines
Dr. Brian Ward, McGill University

Travel Vaccines
Dr. Pierre Plourde, Winnipeg Regional Health Authority

Intradermal Rabies Vaccine
Dr. Ken Gamble, Missionary Health Institute

What's New in the 2006 Canadian Immunization Guide?
Room 2G, 2nd Floor

Chair: Dr. Monika Naus, Chairperson, National Advisory Committee on Immunization

This is an opportunity to get first-hand information from members of the National Advisory Committee on Immunization (NACI) about the key changes to the Guide, including sections that are substantially new, changed, or challenging in terms of keeping up with the changes, and the reasons behind these. In addition to highlighting key areas of focus, the session will provide an opportunity to ask questions and get suggestions in for future enhancements to the Guide and its varied formats.

NACI members:
Dr. Bernard Duval,
(Presentation will be in French)
Dr. Ben Tan,
Dr. Shelley Rechner.

Issues Pertaining to Informed Decision Making and Consent to Immunization
Pan Am Room, 2nd Floor

Chair: Ms. Marie-Adèle Davis, Canadian Paediatric Society

This session will explore the optimal methods to provide information to individuals in order that they may make informed decisions regarding immunization. It will also examine what information is necessary in order to obtain informed consent. The session will highlight the challenges in obtaining consent from individuals with special health needs or from special populations. Lastly, it will provide practical information on how to document an individual’s refusal of immunization, and the legal requirements for health care professionals to obtain informed consent to immunization.

Informed Consent in the Public Health Setting
Ms. Anita Hanrahan, Capital Health, Alberta

Informed Consent for Patients With Health Challenges
Dr. John Yaremko, Paediatrician

Legal Considerations in Obtaining Informed Consent and Documenting Vaccine Refusals
Ms. Margaret Ross, Lawyer

Good Morning, Immunization: The View From Here!
Hall B, 3rd Floor

Chair: Dr. Simon Dobson, National Advisory Committee on Immunization
Mr. André Picard, The Globe and Mail
Dr. Allison McGeer, Mount Sinai
Hospital/Toronto Medical Laboratories
Dr. Horacio Arruda, Ministère de la Santé et
des services sociaux du Québec
Ms. Linda Aylesworth, Global Television

A Starter Kit for Planning Vaccine Programs
Hall B, 3rd Floor

Chair: Ms. Elaine Sartison, Canadian Nurses Association

This session will include a discussion about using an Immunization Framework when trying to decide which newly approved vaccines to introduce in a jurisdiction; the practical aspects of planning for a new vaccine program; and a suggested frame-work for evaluating an existing vaccine program.

An Immunization Framework for Decision Makers
Dr. Karen Grimsrud, Alberta Health and Wellness

Evaluating an Existing Immunization Program: A Proposed Framework
Ms. Wanda White, Government of the Northwest Territories

Safety Syringes, Waterless Hand Cleaning Agents, Vaccine Packaging and the Rest
Ms. Melody Hawryluk, Stonewall Community Health Office

Public Education: What Works, What Doesn't
Room 2E, 2nd Floor

Chair: Ms. Mary Appleton, Canadian Coalition for Immunization Awareness and Promotion

An informal “fireside chat” with front line practitioners who use various strategies and tools to increase public understanding of immunization. The solicitation of questions, input and ideas from the audience will be an important aspect of this session. Come prepared to share your experiences as well as listen to others.

Panellists:
Dr. Danielle Grenier, Paediatrician
Dr. William Libich, Family Physician
Ms. Jan Harder, Public Health Nurse

Increasing Immunization Rates in Practice
Room 2F, 2nd Floor

Chair: Dr. Greg Hammond, Canadian Immunization Committee

Recent trends in immunization rates are concerning; the rates are much lower than recommended. This session will examine analyses and examples of strategies and interventions that positively impact on immunization rates.

Provincial Immunization Strategy
Dr. Shainoor Virani, Provincial Health Office, Alberta

Provincial Immunization
Registry in Manitoba
Ms. Tara Mawhinney, Manitoba Health
Dr. Chris Green, Geographic Mapping of Immunization

How to Encourage Immunization in Physician Practices
Dr. David Connor, Paediatrician

How to Encourage Immunization
in Physician Practices
Dr. David Connor, Paediatrician

First Nations and Inuit Immunization Issues

Room 2G, 2nd Floor
Chair: Dr. Wadieh Yacoub, First Nations and Inuit Health Branch, Health Canada

This session will examine key immunization issues for First Nations and Inuit populations. Speakers will include public health professionals working with the First Nations and Inuit Health Branch of Health Canada and with International Circumpolar Surveillance. Challenges and successes in vaccination programming in First Nations and Inuit communities will be discussed, including unique vaccination needs, local implementation and reaching vulnerable groups.

Implementation of the National Immunization Strategy in First Nations Communities
Dr. Marcus Lem, First Nations and Inuit Health Branch, Health Canada

Immunization in First Nations Communities: The Alberta Experience
Ms. Ruth Richardson, First Nations and Inuit Health Branch, Health Canada

Immunization Program Delivery in Nunatsiavut: Local Challenges and Accomplishments
Ms. Gail Turner, Nunatsiavut Department of Health and Social Development

Vaccines on the Horizon
Pan Am Room, 2nd Floor

Chair: Dr. Bhagirath Singh, Canadian Institutes of Health Research

This session will explore new developments in vaccine technology and the potential for vaccines for emerging diseases that have global impact. Canada's three leading experts will address what new vaccines are on the horizon and how cutting edge technology is helping in this effort. They will also discuss how new vaccine delivery approaches can be used to expand and enhance the existing vaccine supply.

Vaccines for BSE and Prion Disease
Dr. Neil Cashman, University of British Columbia Hospital

Pre- and Post-Exposure Prophylaxes for Marburg and Ebola Viruses: Use of Benign Recombinant Viruses to Combat Highly Lethal Pathogens
Dr. Steven Jones, Public Health Agency of Canada

New Methods to Improve Vaccine Supply
Dr. Wilfred Jefferies, University of British Columbia

Pandemic Vaccines/Research Initiatives, Hall B, 3rd Floor

Chair: Dr. Theresa Tam, Public Health Agency of Canada

New Immunological and Technological Approaches in Vaccine Development
Dr. Lorne Babiuk, University of Saskatchewan

Canadian Preparedness for a Pandemic
Dr. Theresa Tam, Public Health Agency of Canada

Regulatory Issues in Pandemic Vaccine Planning
Dr. Elwyn Griffiths, Health Canada

Professional Education, Town Hall Forum, Hall B, 3rd Floor

Chair: Dr. Barbara Law, Public Health Agency of Canada

Finding the best way to achieve formal and continuing immunization education for health care professionals in an effective, affordable, efficient, sustainable and universal manner is a challenge. Teaching materials and events are necessary, but not necessarily sufficient. During this session, three unique approaches to the issue will be described and discussed.

National Core Learning Objectives for Vaccine Providers: Where We Are and Where We're Going
Dr. Shelly McNeil, Professional Education Working Group

Certification for Immunization Providers: The British Columbia Approach
Ms. Cheryl McIntyre, British Columbia Centre for Disease Control

Innovative Approaches to Interprofessional Education
Dr. Joan Sargeant, Dalhousie University

Special Populations
Room 2E, 2nd Floor

Chair: Ms. Karen Pielak, Canadian Nurses Coalition for Immunization

This session will present information on the unique and complex issues related to the immunization of populations with special health concerns: new immigrants, pregnant women and the immunocompromised.

Immunization Needs of New Canadians
Dr. Reka Gustafson, Vancouver Coastal Health

The immunization needs of new Canadians are unique. The epidemiology of vaccine-preventable diseases in the countries of origin affect which vaccines are indicated. New Canadians’ experience with vaccine-preventable diseases and vaccination influence their attitudes toward immunization. Both the medical and the cultural context of new Canadians need to be considered when providing immunizations. The successes and challenges of the immunization program of a refugee clinic in Vancouver will be used to illustrate how providers can approach the unique needs of this population.

Immunization in Pregnancy
Dr. Deborah Money, British Columbia Children's Hospital

Immunizing the Immunocompromised Populations
Dr. Upton Allen, Hospital for Sick Children, Toronto

The presentation will review the factors affecting the immune response to vaccines in immunosuppressed patients. The roles of specific vaccines will be discussed, including the 7-valent pneumococcal conjugate vaccine and influenza vaccines, among others. Vaccine safety in cancer patients will be addressed as it relates to live vaccines. In addition, we will review issues relating to exposure to measles and varicella, given the potential consequences of these infections in immunosuppressed patients.

Adult Populations
Room 2F, 2nd Floor

Chair: Dr. Ian Gemmill, Canadian Public Health Association/National Specialty Society for Community Medicine

Why routine vaccines for adults need to be a priority in 2006; increasing awareness and immunization rates among adults; special vaccine needs for adult populations, including occupational immunization of health care workers, police, military personnel, for travel and for personal risk.

Vaccines (Like Trix) are Not Just for Kids: An Overview of the Need for Vaccines in Adulthood
Dr. Kevin Laupland, University of Calgary

Promoting Vaccines Among Adults
Dr. Bonnie Henry, British Columbia Centre for Disease Control

Specialty Vaccines for Adults
Dr. Jay Keystone, The Toronto Hospital

Influenza, Room 2G, 2nd Floor

Chair: Dr. Joanne Embree, Canadian Paediatric Society

In this session, three speakers will address the current issues, programmatic controversies and potential solutions related to the routine influenza immunization of adults, children and those living in remote First Nations and Inuit communities.

Routine Immunization and the School Aged Child
Dr. Danuta Skowronski, British Columbia Centre for Disease Control

Does Life Begin at 50? A Discussion of the Issue of the American Recommendations for Routine Immunization of Adults
Dr. Pam Orr, University of Manitoba

Use of Medical Students to Immunize an Entire Community, and Other Solutions to the Trials and Tribulations Related to Influenza in the Northern Communities
Dr. Bruce Martin, University of Manitoba

Protecting Our Nation's Vaccine Supply
Pan Am Room, 2nd Floor

Chair: Ms. Elaine Sartison, Canadian Nurses Association

Find out more about what is being planned nationally to address the ongoing vaccine supply issues; what production problems vaccine manufacturers have to deal with; and the impact of shortages on childhood vaccine programs.

A National Vaccine Supply Strategy
Mr. Alan Thom, Public Health Agency of Canada

Supply Issues in the New Millennium: A Manufacturer's Perspective
Ms. Kathy Estey, sanofi pasteur

Impact on Vaccine Programs
Ms. Michelle Long, Manitoba Health

Dr. John Waters Memorial Lecture: The Vision for Immunization in Canada
Hall B, 3rd Floor

Chair: Dr. Paul Schnee, Dr. John Waters Memorial Committee

Dr. Joanne Embree, Canadian Paediatric Society

The Vision Expands
Hall B, 3rd Floor

Chair: Dr. Shelley Deeks, Public Health Agency of Canada

Dr. Jon Andrus, Pan American Health Organization

The Research Vision
Chair: Dr. Shelley Deeks, Public Health Agency of Canada

Research Initiatives and Acceptance of Vaccine
Dr. Paul Ritvo, Cancer Care Ontario

Toll-Like Receptors, Hall B, 3rd Floor

Chair: Dr. Joanne Embree, Canadian Paediatric Society

Toll-Like Receptors - The New
Frontier in Immunization
Hall B, 3rd Floor
Dr. Keith Fowke, University of Manitoba

The Current State of Challenges to the Industry in Canada
Hall B, 3rd Floor
Mr. Peter Brenders, BIOTECanada

Panel Discussion - Question Period

Ask the Experts, Hall B, 3rd Floor

Chair: Ms. Marie-Adèle Davis, Canadian Paediatric Society

Dr. Joanne Langley, National Advisory Committee on Immunization
Ms. Anita Hanrahan, Capital Health
Dr. Ian Gemmill, public health representative
Dr. James Carson, Paediatrician
Dr. Brian Ward, McGill University

Closing Remarks, Hall B, 3rd Floor

Chair: Dr. Theresa Tam, Public Health Agency of Canada

Dr. Monika Naus, British Columbia Centre for Disease Control and Chairperson, National Advisory Committee on Immunization

Adjournment